Pharma Universalis
ActiveSummary
Pharma Universalis has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €94,403 and a net result of €45,822. Its solvency ranks better than 72% of 9,615 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
On 4 January 2024, Pharma Universalis was incorporated as a private limited company by one natural person, with a starting capital of €5,000.12 Peeters Koen Daniel Wilfried has served as director of the company since 2024.2 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
28-05
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
09-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
08-01
Gazette deed
IncorporationAppointment: Peeters Koen Daniel Wilfried (director) · Founder · Founding capital4 facts ▸
Gazette deed
Incorporation
Appointment: Peeters Koen Daniel Wilfried (director) · Founder · Founding capital4 facts ▸
- Incorporation, 04-01-2024
- Founder, Peeters Koen Daniel Wilfried
- Founding capital, €5,000
- Director appointment, Peeters Koen Daniel Wilfried (director (not named in the articles))
Gazette deedNBB filing
1 of 1 deed read